(Q29036118)

https://doi.org/10.1016%2FS1474-4422%2804%2900936-6

corticobasal degeneration

27 March 2017

main subject

1 reference

Mark J Edwards

2

0 references

Kailash Phatechand Bhatia

series ordinal

4

object named as

Kailash P Bhatia

1 reference

27 March 2017

1

Robert K Mahapatra

1 reference

https://doi.org/10.1016%2FS1474-4422%2804%2900936-6

27 March 2017

author name string

Jonathan M Schott

series ordinal

3

1 reference

https://doi.org/10.1016%2FS1474-4422%2804%2900936-6

27 March 2017

publication date

December 2004

1 reference

https://doi.org/10.1016%2FS1474-4422%2804%2900936-6

27 March 2017

1 reference

https://doi.org/10.1016%2FS1474-4422%2804%2900936-6

27 March 2017

volume

3

1 reference

https://doi.org/10.1016%2FS1474-4422%2804%2900936-6

27 March 2017

issue

12

1 reference

https://doi.org/10.1016%2FS1474-4422%2804%2900936-6

27 March 2017

page(s)

736-743

1 reference

https://doi.org/10.1016%2FS1474-4422%2804%2900936-6

Corticodentatonigral Degeneration With Neuronal Achromasia

27 March 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Cortical degeneration with swollen chromatolytic neurons: its relationship to Pick's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Cortical-basal ganglionic degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

The youngest reported case of corticobasal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Corticobasal degeneration. A clinical study of 36 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Corticobasal degeneration: neuropathologic and clinical heterogeneity.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Familial dementia with swollen achromatic neurons and corticobasal inclusion bodies: a clinical and pathological study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Clinical presentation and pharmacological therapy in corticobasal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Apraxia in corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Apraxia, mechanical problem solving and semantic knowledge: contributions to object usage in corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Dysarthria and orofacial apraxia in corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

The alien hand and related signs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Arm levitation in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Corticobasal degeneration as a cognitive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Corticobasal degeneration: Selected developments

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

The FAB: a Frontal Assessment Battery at bedside.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Dementia as the most common presentation of cortical-basal ganglionic degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

A clinical profile of corticobasal degeneration presenting as primary progressive aphasia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Pathologically confirmed corticobasal degeneration presenting with visuospatial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Pathological heterogeneity of clinically diagnosed corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Alzheimer's disease pathology in motor cortex in dementia with Lewy bodies clinically mimicking corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Pathologic heterogeneity in clinically diagnosed corticobasal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Neurofilament inclusion body disease: a new proteinopathy?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Neurophysiological features in relation to clinical signs in clinically diagnosed corticobasal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Electrophysiological comparison between corticobasal degeneration and progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Role of dopamine transporter imaging in routine clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Neurodegenerative disorders with extensive tau pathology: a comparative study and review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Neurofibrillary tangle parkinsonian disorders--tau pathology and tau genetics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Signature tau neuropathology in gray and white matter of corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Levodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Treatment of dystonic clenched fist with botulinum toxin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021

Bromocriptine treatment for perseveration in demented patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900936-6

7 January 2021